| Year |
Citation |
Score |
| 2018 |
Towner RA, Smith N, Saunders D, Brown CA, Cai X, Ziegler J, Mallory S, Dozmorov MG, Coutinho De Souza P, Wiley G, Kim K, Kang S, Kong DS, Kim YT, Fung KM, et al. OKN-007 Increases temozolomide (TMZ) Sensitivity and Suppresses TMZ-Resistant Glioblastoma (GBM) Tumor Growth. Translational Oncology. 12: 320-335. PMID 30468988 DOI: 10.1016/J.Tranon.2018.10.002 |
0.378 |
|
| 2015 |
Towner RA, Wisniewski AB, Wu DH, Van Gordon SB, Smith N, North JC, McElhaney R, Aston CE, Shobeiri SA, Kropp BP, Greenwood-Van Meerveld B, Hurst RE. A Feasibility Study to Determine whether Clinical Contrast-Enhanced MRI can Detect Increased Bladder Permeability in Patients with Interstitial Cystitis. The Journal of Urology. PMID 26307161 DOI: 10.1016/J.Juro.2015.08.077 |
0.302 |
|
| 2015 |
Coutinho de Souza P, Mallory S, Smith N, Saunders D, Li XN, McNall-Knapp RY, Fung KM, Towner RA. Inhibition of Pediatric Glioblastoma Tumor Growth by the Anti-Cancer Agent OKN-007 in Orthotopic Mouse Xenografts. Plos One. 10: e0134276. PMID 26248280 DOI: 10.1371/Journal.Pone.0134276 |
0.371 |
|
| 2015 |
Towner RA, Ihnat M, Saunders D, Bastian A, Smith N, Pavana RK, Gangjee A. A new anti-glioma therapy, AG119: pre-clinical assessment in a mouse GL261 glioma model. Bmc Cancer. 15: 522. PMID 26177924 DOI: 10.1186/S12885-015-1538-9 |
0.349 |
|
| 2015 |
de Souza PC, Smith N, Atolagbe O, Ziegler J, Njoku C, Lerner M, Ehrenshaft M, Mason RP, Meek B, Plafker SM, Saunders D, Mamedova N, Towner RA. OKN-007 decreases free radicals levels in a preclinical F98 rat glioma model. Free Radical Biology & Medicine. PMID 26119786 DOI: 10.1016/J.Freeradbiomed.2015.06.026 |
0.348 |
|
| 2015 |
de Souza PC, Balasubramanian K, Njoku C, Smith N, Gillespie DL, Schwager A, Abdullah O, Ritchey JW, Fung KM, Saunders D, Jensen RL, Towner RA. OKN-007 decreases tumor necrosis and tumor cell proliferation and increases apoptosis in a preclinical F98 rat glioma model. Journal of Magnetic Resonance Imaging : Jmri. PMID 25920494 DOI: 10.1002/Jmri.24935 |
0.357 |
|
| 2015 |
Mallory S, McNall-Knapp R, DeSouza PC, Smith N, Saunders D, Fung K, Towner R. Tr-12Okn-007: A Novel Compound For Treating Pediatric Glioblastoma Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov061.157 |
0.394 |
|
| 2011 |
He T, Smith N, Saunders D, Doblas S, Watanabe Y, Hoyle J, Silasi-Mansat R, Lupu F, Lerner M, Brackett DJ, Towner RA. Molecular MRI assessment of vascular endothelial growth factor receptor-2 in rat C6 gliomas. Journal of Cellular and Molecular Medicine. 15: 837-49. PMID 20497492 DOI: 10.1111/J.1582-4934.2010.01091.X |
0.319 |
|
| 2010 |
Garteiser P, Doblas S, Watanabe Y, Saunders D, Hoyle J, Lerner M, He T, Floyd RA, Towner RA. Multiparametric assessment of the anti-glioma properties of OKN007 by magnetic resonance imaging. Journal of Magnetic Resonance Imaging : Jmri. 31: 796-806. PMID 20373422 DOI: 10.1002/Jmri.22106 |
0.346 |
|
| 2008 |
Towner RA, Smith N, Doblas S, Tesiram Y, Garteiser P, Saunders D, Cranford R, Silasi-Mansat R, Herlea O, Ivanciu L, Wu D, Lupu F. In vivo detection of c-Met expression in a rat C6 glioma model Journal of Cellular and Molecular Medicine. 12: 174-186. PMID 18194445 DOI: 10.1111/J.1582-4934.2008.00220.X |
0.337 |
|
| 2008 |
Doblas S, Saunders D, Kshirsagar P, Pye Q, Oblander J, Gordon B, Kosanke S, Floyd RA, Towner RA. Phenyl-tert-butylnitrone induces tumor regression and decreases angiogenesis in a C6 rat glioma model. Free Radical Biology & Medicine. 44: 63-72. PMID 18045548 DOI: 10.1016/J.Freeradbiomed.2007.09.006 |
0.411 |
|
| Show low-probability matches. |